Firm’s Successful Efforts in Protecting R & D covering Zika treatments

In support of the research and clinical efforts to combat the Zika virus and save patients from the possible side effects of nerve-based disorders resulting from Zika infections, the Firm has successfully prosecuted a patent directed to the treatment of zika that was granted by the Japanese Patent Office on July 13, 2016.

On July 29, 2016, the Florida Department of Health confirmed the first local Zika transmission in the continental United States at a one-square mile area in Wynwood, a trendy neighborhood just north of downtown Miami.

Earlier, on January 22, 2016, the United States Centers for Disease Control and Prevention activated its Level 1 response to monitor and coordinate the emergency response to Zika in the US including the Caribbean, Brazil, Venezuela and other countries and territories.

Subsequently on Feb. 1, 2016 the World Health Organization (WHO) declared a Public Health Emergency of International Concern. Sporadic zika cases were also detected in Asia, including Bangladesh, Malaysia, Hong Kong, Cambodia, Indonesia, Philippines, Vietnam, Laos, Singapore and Thailand.